Ifp Advisors, Inc Ani Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

Previous 0 NaN%

Previous $0 NaN%

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$57.79 - $72.95 $0 - $0	0 New	0 $0
Q1 2025 May 05, 2025	BUY	$53.93 - $68.36 $0 - $0	0 New	0 $0
Q4 2024 Feb 04, 2025	BUY	$53.35 - $61.74 $0 - $0	0 New	0 $0
Q3 2021 Oct 06, 2021	SELL	$26.48 - $35.99 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$31.86 - $38.6 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$28.4 - $36.14 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$23.69 - $31.47 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$26.38 - $33.1 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$29.93 - $50.1 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	SELL	$30.35 - $67.14 $1,638 - $3,625	-54 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$55.65 - $79.83 $389 - $558	7 Added 14.89%	54 $3,000
Q3 2019 Nov 07, 2019	BUY	$64.7 - $85.39 $3,040 - $4,013	47 New	47 $3,000
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $3,437 - $5,290	-75 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$41.17 - $56.44 $988 - $1,354	-24 Reduced 24.24%	75 $3,000
Q3 2018 Oct 25, 2018	BUY	$52.95 - $71.34 $900 - $1,212	17 Added 20.73%	99 $0
Q2 2018 Aug 07, 2018	SELL	$56.38 - $68.08 $2,424 - $2,927	-43 Reduced 34.4%	82 $0
Q1 2018 Jun 03, 2019	BUY	$56.98 - $72.41 $626 - $796	11 Added 9.65%	125 $8,000
Q1 2018 May 09, 2018	SELL	$56.98 - $72.41 $626 - $796	-11 Reduced 8.8%	114 $0
Q4 2017 Jan 24, 2018	SELL	$53.3 - $74.56 $1,385 - $1,938	-26 Reduced 17.22%	125 $0
Q2 2017 Jun 03, 2019	BUY	N/A	16 Added 11.85%	151 $7,000
Q1 2017 Jun 03, 2019	BUY	N/A	18 Added 15.38%	135 $7,000
Q4 2016 Jun 03, 2019	BUY	N/A	100 Added 588.24%	117 $7,000
Q2 2016 Jun 03, 2019	BUY	N/A	17	17 $1,000

249

19.4M

19.9K

12.8K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.58B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.